# Hpx•apoB Product as a Biomarker for Coronary Artery Disease

> **NCT07126132** · — · COMPLETED · sponsor: **Shiyan City Renmin Hospital** · enrollment: 460 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Coronary Angiography
- **DIAGNOSTIC_TEST:** Hpx•apoB Product Measurement

## Key facts

- **NCT ID:** NCT07126132
- **Lead sponsor:** Shiyan City Renmin Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 460 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07126132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07126132, "Hpx•apoB Product as a Biomarker for Coronary Artery Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07126132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*